The link below is for a recent PNAS publication. It is somewhat controversial in the sirtuin research world. As potent activator of sirt1, resveratrol from red wine has been a hot topic for diabetes therapies, and data also showed it is metabolically beneficial, yet this article certainly shed some shadow on sirtuin research and pharmarceutic investments.

sirt1 knockdown improves liver insulin sensitivity